Menu

Blog

Oct 5, 2024

‘Amazing’ trial shows drug combination stops lung cancer advancing for longer

Posted by in category: biotech/medical

Exclusive: Global trial finds treatment with amivantamab and lazertinib halts progression for average of 23.7 months.

Leave a reply